JMJD2D Antibody (KDM4D)
Covalent modification of histones plays critical role in regulating chromatin structure and transcription. While most covalent histone modifications are reversible, only recently has it been established that methyl groups are subject to enzymatic removal from histones. A family of novel JmjC domain-containing histone demethylation (JHDM) enzymes have been identified that perform this specific function. Histone demethylation by JHDM proteins requires cofactors Fe (II) and alpha-ketoglutarate. Family members include JHDM1 (demethylating histone 3 at lysine 36), and JHDM2A as well as JMJD2CH3K9 (both of which demethylate histone 3 at lysine 9) . Contributions of histone demethylase activity to tumor development, decreases in cell proliferation, and hormone-dependent transcriptional activation have been observed.
Product Specifications
CAS Number
9007-83-4
Specifications
Western blot: 1:1000
UniProt
Q6B0I6
Host
Rabbit
Reactivity
Human
Immunogen
A portion of amino acids 484-516 from the human protein was used as the immunogen for this JMJD2D antibody.
Clonality
Polyclonal
Isotype
Ig
Applications
WB, ELISA
Purity
Purified
Format
Purified
Buffer
In 1X PBS, pH 7.4, with 0.09% sodium azide
Reconstitution
Aliquot the JMJD2D antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitations
This JMJD2D antibody is available for research use only.
Storage Conditions
Aliquot the JMJD2D antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
Formulation
In 1X PBS, pH 7.4, with 0.09% sodium azide
Applications Notes
Titration of the JMJD2D antibody may be required due to differences in protocols and secondary/substrate sensitivity.
Image Legend
Western blot analysis of JMJD2D antibody and HeLa lysate
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
